Connect Biopharma Holdings Limited
CNTB
$2.55
$0.010.39%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 31.49M | 46.03M | 44.34M | 54.78M | 71.77M |
| Total Receivables | 2.96M | 2.70M | 161.00K | 174.00K | 193.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 4.18M | 15.27M | 6.43M | 7.64M | 5.57M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | 228.00K |
| Total Current Assets | 38.62M | 55.02M | 50.93M | 62.60M | 77.76M |
|
|
|||||
| Total Current Assets | 38.62M | 55.02M | 50.93M | 62.60M | 77.76M |
| Net Property, Plant & Equipment | 4.16M | 4.36M | 4.46M | 4.67M | 4.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 42.00K | 43.00K | 45.00K | 47.00K | 48.00K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 646.00K | 646.00K | 646.00K | 45.00K | 45.00K |
| Total Assets | 43.47M | 60.07M | 56.08M | 67.36M | 82.73M |
|
|
|||||
| Total Accounts Payable | 2.02M | 4.31M | 1.96M | 1.99M | 2.29M |
| Total Accrued Expenses | 13.89M | 12.33M | 11.16M | 8.93M | 7.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 393.00K | 406.00K | 322.00K | 336.00K | 350.00K |
| Total Finance Division Other Current Liabilities | -- | -- | 167.00K | 165.00K | 164.00K |
| Total Other Current Liabilities | -- | -- | 167.00K | 165.00K | 164.00K |
| Total Current Liabilities | 16.30M | 17.05M | 13.61M | 11.43M | 10.74M |
|
|
|||||
| Total Current Liabilities | 16.30M | 17.05M | 13.61M | 11.43M | 10.74M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 203.00K | 287.00K | 368.00K | 445.00K | 520.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 107.00K | 111.00K | 114.00K | 118.00K | 122.00K |
| Total Liabilities | 16.61M | 17.44M | 14.10M | 11.99M | 11.38M |
|
|
|||||
| Common Stock & APIC | 465.52M | 464.10M | 444.19M | 442.55M | 441.42M |
| Retained Earnings | -437.52M | -420.23M | -400.84M | -385.73M | -368.53M |
| Treasury Stock & Other | -1.14M | -1.24M | -1.37M | -1.46M | -1.56M |
| Total Common Equity | 26.86M | 42.62M | 41.98M | 55.37M | 71.34M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 26.86M | 42.62M | 41.98M | 55.37M | 71.34M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 26.86M | 42.62M | 41.98M | 55.37M | 71.34M |
|
|
|||||